Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Fidelity Low Duration Bond Factor ETF
FLDR
$1.98B
| $18.7M | ﹤0.01% |
371,438
+6,572
| +2% | +$331K |
|
3002
Ultrapar
UGP
$6.73B
| $18.7M | ﹤0.01% |
4,947,134
-1,230,491
| -20% | -$4.87M |
|
3003
Werner Enterprises
WERN
$2.34B
| $18.6M | ﹤0.01% |
621,431
-15,176
| -2% | -$417K |
|
3004
Innospec
IOSP
$2.14B
| $18.6M | ﹤0.01% |
243,535
-10,218
| -4% | -$772K |
|
3005
Global X SuperDividend ETF
SDIV
$1.22B
| $18.6M | ﹤0.01% |
775,126
+85,977
| +12% | +$2.05M |
|
3006
Talos Energy
TALO
$2.29B
| $18.6M | ﹤0.01% |
1,689,320
+259,876
| +18% | +$2.72M |
|
3007
Trustmark
TRMK
$2.76B
| $18.6M | ﹤0.01% |
477,472
+122,613
| +35% | +$4.77M |
|
3008
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$403M
| $18.5M | ﹤0.01% |
105,850
-68,851
| -39% | -$12.1M |
|
3009
Vertex
VERX
$2.16B
| $18.5M | ﹤0.01% |
924,888
-48,554
| -5% | -$1.05M |
|
3010
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$658M
| $18.5M | ﹤0.01% |
281,308
+10,539
| +4% | +$700K |
|
3011
CONMED
CNMD
$1.36B
| $18.5M | ﹤0.01% |
454,849
+161,885
| +55% | +$7.04M |
|
|
TEI
3012
Templeton Emerging Markets Income Fund
TEI
$313M
| $18.5M | ﹤0.01% |
2,860,983
+151,687
| +6% | +$967K |
|
|
TGB
3013
Trekor Metals
TGB
$2.5B
| $18.4M | ﹤0.01% |
3,248,900
-2,525,005
| -44% | -$11.9M |
|
3014
abrdn Physical Palladium Shares ETF
PALL
$611M
| $18.4M | ﹤0.01% |
632,065
+81,965
| +15% | +$2.21M |
|
3015
TRI-Continental Corp
TY
$1.86B
| $18.4M | ﹤0.01% |
562,413
+61,440
| +12% | +$2.08M |
|
3016
ProPetro Holding
PUMP
$1.3B
| $18.3M | ﹤0.01% |
1,928,080
+1,039,893
| +117% | +$9.04M |
|
3017
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $18.3M | ﹤0.01% |
464,600
+44,725
| +11% | +$1.77M |
|
3018
Suzano
SUZ
$10.3B
| $18.3M | ﹤0.01% |
1,955,831
+74,170
| +4% | +$674K |
|
3019
DoubleLine Mortgage ETF
DMBS
$703M
| $18.3M | ﹤0.01% |
367,871
+11,208
| +3% | +$558K |
|
3020
First Trust Japan AlphaDEX Fund
FJP
$244M
| $18.3M | ﹤0.01% |
271,912
-3,812
| -1% | -$254K |
|
3021
Simulations Plus
SLP
$372M
| $18.2M | ﹤0.01% |
1,000,149
-297,274
| -23% | -$5.22M |
|
3022
Ingevity
NGVT
$2.63B
| $18.2M | ﹤0.01% |
307,969
-20,942
| -6% | -$1.14M |
|
3023
Goldman Sachs BDC
GSBD
$998M
| $18.2M | ﹤0.01% |
1,957,343
-537,810
| -22% | -$5.27M |
|
3024
National Health Investors
NHI
$3.86B
| $18.1M | ﹤0.01% |
237,569
+40,026
| +20% | +$3.07M |
|
3025
Rentokil
RTO
$14.5B
| $18.1M | ﹤0.01% |
615,281
-464,286
| -43% | -$12.9M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.